Loading clinical trials...
Loading clinical trials...
The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma: a Prospective Cohort Study
Spinal hemangioma is one of the most common benign vertebral tumours. Being mostly asymptomatic, it is still associated with a pain syndrome especially if encroaches into the neural canal. This study is organised to evaluate the efficacy and safety of β-blockers drugs in adults with spinal hemangioma.
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
No
The Vascular Anomalies Center (VAC) "Hemangioma"
Moscow, Russia
Start Date
December 1, 2021
Primary Completion Date
December 1, 2022
Completion Date
December 1, 2023
Last Updated
November 3, 2021
1,000
ESTIMATED participants
Atenolol Pill
DRUG
Propranolol Pill
DRUG
Lead Sponsor
Center for Vascular Pathology, Moscow
NCT07224451
NCT03839914
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06587022